- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.11.25 | Resilience - the importance of maintaining our well-being | ||
| 04.11.25 | Lilly announces plan for new $3bn facility to boost manufacturing in Europe | ||
| 04.11.25 | Uniphar strengthens US leadership team amid expansion | ||
| 04.11.25 | Physician-driven, AI-supported: addressing the clinical trial access gap | ||
| 03.11.25 | Novartis reports positive phase 3 results for Cosentyx in polymyalgia rheumatica | ||
| 03.11.25 | Uniphar announces US expansion and company integration | ||
| 03.11.25 | Turning connection into action: VML Health's first Patient Advocacy Summit ignites collaboration in Berlin | ||
| 03.11.25 | Creativity cages | ||
| 31.10.25 | Novartis presents new positive data for rheumatic autoimmune disease treatment | ||
| 31.10.25 | Lilly to invest $1.2bn in Puerto Rico manufacturing site | ||
| 31.10.25 | A quest for the crown: ruling digital relevance in the age of LLMs | ||
| 31.10.25 | The three non-negotiable pillars of Alzheimer's blood testing | ||
| 30.10.25 | Kyowa Kirin and University Hospitals Birmingham announce new survival data in rare disease study | ||
| 30.10.25 | UCB's Finteplap shows positives results for Lennox-Gastaut syndrome | ||
| 30.10.25 | Navigating the 'Patient Metro' - a journey full of insights | ||
| 29.10.25 | FDA Fast Track designation given to Enterome's follicular lymphoma treatment | ||
| 29.10.25 | Medicus Pharma recruits first patient in cancer patch trial | ||
| 29.10.25 | Aspire Pharma - enhancing the patient experience through stakeholder engagement | ||
| 28.10.25 | GSK's Blenrep approved by FDA for multiple myeloma | ||
| 28.10.25 | Medherant announces positive phase 1 results for testosterone patch for women | ||
| 28.10.25 | From insight to impact: strengthening stakeholder engagement across the patient journey | ||
| 27.10.25 | Novartis to acquire Avidity Biosciences in deal worth $12bn | ||
| 27.10.25 | BMS, Macmillan and 11 NHS Trusts publish report on cancer treatment prehabilitation | ||
| 24.10.25 | Corcept Therapeutics reports positive phase 3 results in ovarian cancer treatment | ||
| 24.10.25 | ProImmune expands into new global headquarters in Oxford |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.